These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15336316)

  • 1. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.
    Efferth T; Benakis A; Romero MR; Tomicic M; Rauh R; Steinbach D; Häfer R; Stamminger T; Oesch F; Kaina B; Marschall M
    Free Radic Biol Med; 2004 Oct; 37(7):998-1009. PubMed ID: 15336316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modes of action of artesunate in tumor cell lines.
    Efferth T; Sauerbrey A; Olbrich A; Gebhart E; Rauch P; Weber HO; Hengstler JG; Halatsch ME; Volm M; Tew KD; Ross DD; Funk JO
    Mol Pharmacol; 2003 Aug; 64(2):382-94. PubMed ID: 12869643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate.
    Kelter G; Steinbach D; Konkimalla VB; Tahara T; Taketani S; Fiebig HH; Efferth T
    PLoS One; 2007 Aug; 2(8):e798. PubMed ID: 17726528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
    Chitambar CR; Wereley JP
    Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.
    Ooko E; Saeed ME; Kadioglu O; Sarvi S; Colak M; Elmasaoudi K; Janah R; Greten HJ; Efferth T
    Phytomedicine; 2015 Oct; 22(11):1045-54. PubMed ID: 26407947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins.
    Anfosso L; Efferth T; Albini A; Pfeffer U
    Pharmacogenomics J; 2006; 6(4):269-78. PubMed ID: 16432535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate.
    Efferth T; Volm M
    In Vivo; 2005; 19(1):225-32. PubMed ID: 15796179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
    Hedley D; Rugg C; Musgrove E; Taylor I
    J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
    Nakase I; Lai H; Singh NP; Sasaki T
    Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells.
    Chen H; Davidson T; Singleton S; Garrick MD; Costa M
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):275-87. PubMed ID: 16039939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
    Jones DT; Trowbridge IS; Harris AL
    Cancer Res; 2006 Mar; 66(5):2749-56. PubMed ID: 16510596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of K562 cell transferrin receptors by exogenous iron.
    Rudolph NS; Ohlsson-Wilhelm BM; Leary JF; Rowley PT
    J Cell Physiol; 1985 Mar; 122(3):441-50. PubMed ID: 2981898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron deficiency can upregulate expression of transferrin receptor at both the mRNA and protein level.
    Tong X; Kawabata H; Koeffler HP
    Br J Haematol; 2002 Feb; 116(2):458-64. PubMed ID: 11841452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin.
    Li LN; Zhang HD; Yuan SJ; Yang DX; Wang L; Sun ZX
    Eur J Pharmacol; 2008 Jun; 588(1):1-8. PubMed ID: 18448095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antioxidant genes for the activity of artesunate against tumor cells.
    Efferth T; Briehl MM; Tome ME
    Int J Oncol; 2003 Oct; 23(4):1231-5. PubMed ID: 12964009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.